MXPA05003818A - Perfilamiento de la expresion genica de muestras ffpe. - Google Patents

Perfilamiento de la expresion genica de muestras ffpe.

Info

Publication number
MXPA05003818A
MXPA05003818A MXPA05003818A MXPA05003818A MXPA05003818A MX PA05003818 A MXPA05003818 A MX PA05003818A MX PA05003818 A MXPA05003818 A MX PA05003818A MX PA05003818 A MXPA05003818 A MX PA05003818A MX PA05003818 A MXPA05003818 A MX PA05003818A
Authority
MX
Mexico
Prior art keywords
gene expression
expression profiling
ffpe samples
data
samples
Prior art date
Application number
MXPA05003818A
Other languages
English (en)
Inventor
Salunga Ranelle
Original Assignee
Arcturus Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcturus Bioscience Inc filed Critical Arcturus Bioscience Inc
Publication of MXPA05003818A publication Critical patent/MXPA05003818A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Se proporcionan metodos y composiciones relacionadas con la generacion y uso de datos de expresion genica de muestras de tejido que se han fijado e incrustado. Los datos pueden ser almacenados electronicamente e implementados, asi como usados para aumentar la diagnosis y el tratamiento de enfermedades.
MXPA05003818A 2002-10-11 2003-10-10 Perfilamiento de la expresion genica de muestras ffpe. MXPA05003818A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41810302P 2002-10-11 2002-10-11
US10/329,282 US7364846B2 (en) 2002-10-11 2002-12-23 Gene expression profiling from FFPE samples
PCT/US2003/032345 WO2004033660A2 (en) 2002-10-11 2003-10-10 Gene expression profiling from ffpe samples

Publications (1)

Publication Number Publication Date
MXPA05003818A true MXPA05003818A (es) 2005-10-05

Family

ID=32072932

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05003818A MXPA05003818A (es) 2002-10-11 2003-10-10 Perfilamiento de la expresion genica de muestras ffpe.

Country Status (9)

Country Link
US (10) US7364846B2 (es)
EP (3) EP2484777A1 (es)
JP (1) JP2006501857A (es)
AT (1) ATE527377T1 (es)
AU (1) AU2003282608A1 (es)
CA (1) CA2500603A1 (es)
MX (1) MXPA05003818A (es)
NZ (1) NZ539124A (es)
WO (1) WO2004033660A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364846B2 (en) * 2002-10-11 2008-04-29 Molecular Devices Corporation Gene expression profiling from FFPE samples
MY138544A (en) * 2003-06-26 2009-06-30 Neuramatix Sdn Bhd Neural networks with learning and expression capability
ATE554166T1 (de) † 2003-07-25 2012-05-15 Life Technologies Corp Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe
DK1899484T3 (da) 2005-06-03 2015-11-23 Biotheranostics Inc Identifikation af tumorer og væv
US7451122B2 (en) * 2006-03-29 2008-11-11 Honeywell International Inc. Empirical design of experiments using neural network models
JP2008043332A (ja) * 2006-08-17 2008-02-28 Panomics Inc 組織スライドからの核酸定量
KR101773408B1 (ko) * 2010-04-22 2017-08-31 도레이 카부시키가이샤 ａＲＮＡ의 조제방법 및 유전자 발현의 해석방법
TWI425977B (zh) 2010-11-24 2014-02-11 Ind Tech Res Inst 將福馬林固定石蠟包埋之組織進行脫蠟的方法與其套組
EP2468862A1 (en) * 2010-12-23 2012-06-27 Qiagen GmbH Method and kit for processing wax-embedded biological samples
EP2744916A4 (en) 2011-07-13 2015-06-17 Primeradx Inc MULTIMODAL METHODS FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF MULTIPLE NUCLEIC ACIDS IN A SAMPLE
US8852919B2 (en) 2011-11-17 2014-10-07 Rheonix, Inc. Microfluidic apparatus, method, and applications
JP6220405B2 (ja) * 2013-01-24 2017-10-25 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 染色されたＦＦＰＥＴ切片からマイクロダイセクションした材料のＲＴ−ｑＰＣＲ分析
WO2014160645A2 (en) 2013-03-15 2014-10-02 Biotheranostics, Inc. Neuroendocrine tumors
CN111528219B (zh) * 2020-05-13 2022-03-15 上海市计量测试技术研究院 一种用于t淋巴细胞亚群计数标准物质的冻干保护剂及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675297A (en) * 1981-02-23 1987-06-23 The Regents Of The University Of California Genes encoding bovine prolactin
US5545522A (en) 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
US5155018A (en) * 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
DE4321904B4 (de) * 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
CA2153215A1 (en) * 1994-07-06 1996-01-07 Lu Wang Treatment of paraffin embedded tissue for gene analysis
US5698410A (en) * 1995-06-07 1997-12-16 Mount Sinai School Of Medicine Of The City University Of New York Highly sensitive immunocytochemical method for diagnosis of malignant effusions
US5981235A (en) * 1996-07-29 1999-11-09 Promega Corporation Methods for isolating nucleic acids using alkaline protease
TW546381B (en) * 1997-04-18 2003-08-11 Chugai Pharmaceutical Co Ltd Transcriptional regulator containing a bromo-domain
US6183995B1 (en) * 1997-09-05 2001-02-06 Lifespan Biosciences, Inc. Methods of measuring gene expression using wax-embedded tissue specimens
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
AU1926899A (en) * 1997-12-19 1999-07-12 Affymetrix, Inc. Exploiting genomics in the search for new drugs
US6136537A (en) * 1998-02-23 2000-10-24 Macevicz; Stephen C. Gene expression analysis
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
DE19856064C2 (de) * 1998-12-04 2000-11-30 Invitek Gmbh Universelles Verfahren zur Isolierung von DNA aus beliebigen Ausgangsmaterialien
US6429027B1 (en) * 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US6248535B1 (en) * 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
EP1276702A2 (en) * 2000-03-31 2003-01-22 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
EP1328293B1 (en) * 2000-05-10 2012-02-15 Signe BioPharma Inc. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
EP1299562A1 (en) * 2000-06-30 2003-04-09 Aros Applied Biotechnology Aps Gene expression in biological conditions
US6713257B2 (en) * 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
US6794141B2 (en) 2000-12-22 2004-09-21 Arcturus Bioscience, Inc. Nucleic acid amplification
JP2002262882A (ja) * 2001-03-12 2002-09-17 Nisshinbo Ind Inc Ｒｎａの増幅法
JP2004519247A (ja) * 2001-03-20 2004-07-02 オーソ・クリニカル・ダイアグノスティックス・インコーポレーテッド 発現プロファイルおよび使用法
HUP0400659A3 (en) * 2001-07-24 2005-06-28 Zhu Zhou Woodbridge Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
US9201067B2 (en) * 2003-03-05 2015-12-01 Posco Size-controlled macromolecule
DK1918386T3 (da) * 2002-03-13 2012-01-02 Genomic Health Inc Genekspressionsprofiler i biopsier af tumorvæv
US7364846B2 (en) * 2002-10-11 2008-04-29 Molecular Devices Corporation Gene expression profiling from FFPE samples

Also Published As

Publication number Publication date
US20120316084A1 (en) 2012-12-13
US20110034346A1 (en) 2011-02-10
JP2006501857A (ja) 2006-01-19
EP1549769A4 (en) 2007-04-25
WO2004033660A2 (en) 2004-04-22
US8012688B2 (en) 2011-09-06
US7723039B2 (en) 2010-05-25
US8895269B2 (en) 2014-11-25
US20090082215A1 (en) 2009-03-26
CA2500603A1 (en) 2004-04-22
US20120245046A1 (en) 2012-09-27
US20040072305A1 (en) 2004-04-15
ATE527377T1 (de) 2011-10-15
EP1549769B1 (en) 2011-10-05
US20200362393A1 (en) 2020-11-19
NZ539124A (en) 2008-12-24
US20180094297A1 (en) 2018-04-05
EP2484777A1 (en) 2012-08-08
US20150225776A1 (en) 2015-08-13
US8435739B2 (en) 2013-05-07
WO2004033660A3 (en) 2004-08-26
US7364846B2 (en) 2008-04-29
US20100197511A1 (en) 2010-08-05
EP1549769A2 (en) 2005-07-06
US20150152478A1 (en) 2015-06-04
EP2330217A1 (en) 2011-06-08
US7879555B2 (en) 2011-02-01
AU2003282608A1 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
TW200612918A (en) Lonidamine analogs
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
AU2003270280A1 (en) Use of native zein for improving the condition of hair, and corresponding agent
TW200637522A (en) Skin treatment articles and methods
MXPA05005107A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
IL182417A0 (en) Mitotic kinesin inhibitors and methods of use thereof
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
GB0223040D0 (en) Therapeutic compounds
EP1553912A4 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
RS89204A (en) Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease
NO20055741L (no) Nye kjemiske forbindelser
GB0121490D0 (en) Ciompounds
EP1684758A4 (en) METHODS AND COMPOSITIONS USING THALIDOMIDE FOR THE TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
EP1546182A4 (en) COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING TUMORS
DE502004008793D1 (es)